Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London · Delayed Price · Currency is GBP · Price in GBX 699.53
+9.53 (1.38%)
May 26, 2026, 4:16 PM GMT
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 46.92 million as of May 26, 2026. Its market cap has increased by 491.09% in one year.
Market Cap
46.92M
Enterprise Value
47.29M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
699.53
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 10.68M to 46.92M, an increase of 339.27%. That is a compound annual growth rate of 18.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 46.92M | 35.78% |
| Dec 31, 2025 | 34.56M | 143.47% |
| Dec 31, 2024 | 14.19M | -47.51% |
| Dec 29, 2023 | 27.04M | 108.28% |
| Dec 30, 2022 | 12.98M | -29.33% |
| Dec 31, 2021 | 18.37M | -56.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioventix | 87.52M |
| Faron Pharmaceuticals Oy | 82.80M |
| Ondine Biomedical | 77.93M |
| 4basebio | 75.07M |
| hVIVO | 55.65M |
| Poolbeg Pharma | 35.54M |
| Sareum Holdings | 28.41M |
| ImmuPharma | 26.83M |